Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment

Table 2 Comparisons of posttreatment change scales for pain intensity

Pain intensity with numerical rating scale
Decrease^a				No Change^b	Increase^a
	≥7	4-6	1-3	0	1-4	≥5
	N (%)	N (%)	N (%)	N (%)	N (%)	N (%)
Day 1-2	0 (0%)	8 (8.3%)	43 (44.8%)	29 (30.2%)	14 (14.6%)	2 (2.1%)
Day 1-3	2 (2.1%)	13 (13.5%)	43 (44.8%)	24 (25.0%)	13 (13.5%)	1 (1.0%)
Day 2-3	0 (0%)	6 (6.3%)	39 (40.6%)	40 (41.7%)	10 (10.4%)	1 (1.0%)

^aDecrease (increase) was defined as a change in numerical rating scale (NRS) pain intensity of more than 1
^bNo change was defined as a change in numerical rating scale (NRS) pain intensity of less than 1

ISSN: 1472-684X